Magenta

Mount Sinai Morningside

Mount Sinai Queens

The Mount Sinai Hospital

Mount Sinai West

Chlamydia

Dengue Fever

Fungal Infections

Genital Herpes

Giardiasis

Gonorrhea

HIV Testing And Treatment Program

HIV and AIDS

HPV Testing And Treatment

Hepatitis A

Hepatitis A Vaccine

Hepatitis B

Hepatitis B Vaccine

Hepatitis C

Hepatitis C Testing

Infectious Disease Consult

Long-Acting Injectable PrEP

MRSA

Malaria

Measles / Rubeola

Meningococcal Vaccine

Non-bacterial Lung Infection

Non-tuberculous Mycobacterial Infections

Opportunistic Infections

Osteomyelitis

Pneumonia

PrEP/nPEP

Pyelonephritis

STI Testing And Treatment

Sexually Transmitted Infections

Shingles

Syphilis

Tetanus Vaccine

Travel Medicine

Traveler's Diarrhea

Tropical Disease / Parasite / Malaria

Tuberculosis

Typhoid Fever

Typhoid Vaccine

Urinary Tract Infection

Varicella Vaccine

Yellow Fever Vaccine

Book with a provider you have seen before

FOLLOW UP

Book with a provider you have not seen before

NEW PATIENT

Book a virtual visit with a provider you have seen before

VIDEO VISIT - FOLLOW UP

Book a virtual visit with a provider you have not seen before

VIDEO VISIT - NEW PATIENT

Infectious Disease

Department of Medicine - Infectious Disease

Institute for Advanced Medicine - Jack Martin Fund Center

Infectious Diseases

Medicine

PROFESSOR

<p>Dr. Fierer's research interests are focused on the study of acute Hepatitis C (HCV) infection in HIV-infected patients.  Hepatitis C infection is highly prevalent in HIV-infected people, but Hepatitis C is rarely diagnosed during the acute phase (first 6 months) of infection and so little is known about the early course of Hepatitis C infection.  Further, people who are already HIV-infected at the time they contract HCV infection may be at particular risk of having significant liver disease:  a preliminary study in collaboration with Drs. Branch and Dieterich showed the presence of moderately advanced liver damage in HIV-infected people who have acute HCV infection.  Dr. Fierer has initiated a larger study to evaluate HIV-infected patients referred by their physicians for acute HCV infection to further investigate the early effects of this infection on liver pathology, on the natural history of the disease, on the effectiveness of treatment, and of the mode of transmission.</p>

Internal Medicine

Schedule An Appointment

Daniel S Fierer, MD